Oncology Books

2618 products


  • Evidence-Based Networks Ltd 500 Single Best Answers for the Medical Oncology

    15 in stock

    Book SynopsisWritten by senior trainees and verified by experienced medical oncology consultants in the style of the specialty certificate exam, this collection of 500 single best answers offers an ideal preparation for success in the Specialty Certificate Examination in Medical Oncology.Table of ContentsAcute oncology, Breast cancer, Carcinoma of unknown primary, Colorectal and anal cancer, Gynaecological cancers, Haematological cancers, Less common cancers, Lung and thoracic cancers, Professional skills, Sarcoma, Scientific basis of malignancy, Skin cancers, Supportive care therapies, Systemic anti-cancer therapies, Upper gastrointestinal and hepatobiliary cancers, Urological and germ cell cancers

    15 in stock

    £39.99

  • Evidence-Based Networks Ltd Lymphoid Malignancies

    15 in stock

    Book SynopsisThis handbook provides a visual presentation of lymphoproliferative disorders, lymphoid leukaemias and plasma cell neoplasms. Pertinent clinical information relating to clinical presentation, differential diagnosis, treatments and prognostic indicators are concisely outlined, using numerous graphics and citing key references in the field.Table of ContentsThe molecular basis of lymphoma, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia/small lymphocytic lymphoma and monoclonal B-cell lymphocytosis, B-cell prolymphocytic leukaemia, Follicular lymphoma, Mantle cell lymphoma, Lymphoplasmacytic lymphoma, Nodal marginal zone lymphoma, Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma), Splenic marginal zone lymphoma, Hairy cell leukaemia, Hairy cell leukaemia variant and splenic diffuse red pulp small B-cell lymphoma, Burkitt lymphoma, Diffuse large B-cell lymphoma, Other B-cell lymphomas, AIDS-related and other immunodeficiency-related lymphomas, Adult T-cell leukaemia/lymphoma, Mycosis fungoides, Sezary syndrome and other cutaneous T-cell lymphomas, T-cell large granular lymphocytic leukaemia and chronic lymphoproliferative disorder of NK cells, Aggressive NK-cell leukaemia, T-cell prolymphocytic leukaemia, T follicular helper cell lymphomas, Anaplastic T-cell lymphoma, Other T-cell lymphomas, Multiple myeloma (plasma cell myeloma), Monoclonal gammopathies of undetermined significance, Other plasma cell neoplasms, Hodgkin lymphoma

    15 in stock

    £49.99

  • Flow Cytometry of Hematological Malignancies

    John Wiley and Sons Ltd Flow Cytometry of Hematological Malignancies

    3 in stock

    Book SynopsisFlow Cytometry of Hematological Malignancies Flow cytometric analysis is often integral to the swift and accurate diagnosis of leukemias and lymphomas of the blood, bone marrow, and lymph nodes. However, in the fast-moving and expanding field of clinical hematology, in can be challenging to remain up to speed with the latest biological research and technological innovations. Flow Cytometry of Hematological Malignancies has been designed to provide all those working in hematological oncology with a practical, cutting-edge handbook, featuring clear and fully illustrated guidance on all aspects of cytometry's role in diagnosis and analysis. This essential second edition includes: Explorations of more than 70 antigens Full-color illustrations throughout New descriptions of recently discovered markers WHO classifications of hematological neoplastic diseases Helpful tips for result interpretation and analysis Featuring all this andTable of ContentsForeword to the Second Edition xiby Michael J. Borowitz Foreword to the First Edition xiiby Maryalice Stetler-Stevenson Foreword to the First Edition xiiiby Bruno Brando Preface to the Second Edition xv Preface to the First Edition xvi Abbreviations xvii 1 Antigens 1 Clustered (CD) Antigens CD1 3 CD2 5 CD3 8 CD4 17 CD5 21 CD7 24 CD8 26 CD10 30 CD11b 35 CD11c 38 CD13 40 CD14 44 CD15 46 CD16 49 CD19 52 CD20 55 CD22 59 CD23 61 CD24 64 CD25 66 CD26 67 CD27 69 CD28 70 CD30 71 CD33 73 CD34 77 CD38 79 CD43 81 CD45 82 CD45 Isoforms 87 CD49 90 CD56 93 CD57 96 CD61 97 CD62L 98 CD64 99 CD65 101 CD66c 102 CD71 103 CD79 104 CD81 107 CD103 108 CD117 110 CD123 112 CD138 113 CD200 114 CD305 116 CD307 (IRTA) Antigen Family 117 CD371 118 Non clustered (or primarily known with other names) antigens Bcl‐2 Protein 119 Chemokines and Chemokine Receptors 121 CRLF2 128 Cytotoxic Proteins 129 HLA‐DR 130 Immunoglobulins 132 KIR, CD158 isoforms 136 Myeloperoxidase (MPO) 139 NG2 140 PCA‐1 141 ROR1 141 SLAM Molecules and SLAM‐associated Protein (SAP) 142 SOX11 144 T‐cell Receptor (TCR) 145 Terminal Deoxy‐nucleotidyl‐transferase (TdT) 148 Toll‐like Receptors (TLR) 150 VS38 151 ZAP‐70 152 2 Diseases 155 Myeloproliferative neoplasms 157 Chronic myeloid leukemia (CML) 157 Myeloproliferative neoplasms other than CML 160 Chronic neutrophilic leukemia (CNL) 160 Polycythemia vera (PV) 160 Primary myelofibrosis (PMF) 160 Essential thrombocythemia (ET) 160 Chronic eosinophilic leukemia (CEL) 161 Mastocytosis 162 Acute mast‐cell leukemia (AMCL) 162 Chronic mast‐cell leukemia (CMCL) 163 Myelomastocytic leukemia (MML) 163 Myelodysplastic/myeloproliferative neoplasms 164 Chronic myelomonocytic leukemia (CMML) 164 Other myelodysplastic/myeloproliferative neoplasms and related conditions 167 Juvenile myelomonocytic leukemia (JMML) 167 Atypical CML bcr/abl negative (ACML) 167 RAS‐associated autoimmune leukoproliferative disorder (RALD) 167 Myelodysplastic syndromes 168 Myeloid neoplasms with germline predisposition 171 Acute myeloid leukemias 172 AMLs with recurrent genetic anomalies 173 AMLs with chromosomal anomalies 173 AMLs with gene mutations 180 Relationships between genotype and phenotype in cases of AML not recognized as separate entities in WHO 2017 181 AMLs with myelodysplasia‐related changes (AML‐MRC) 182 AMLs not otherwise specified 182 AML with minimal differentiation 182 AML without maturation 183 AML with maturation 183 Acute myelomonocytic leukemia (AMMoL) 183 Acute monoblastic and monocytic leukemia (AMoL) 184 Pure erythroid leukemia (PEL) 185 Acute megakaryoblastic leukemia (AMKL) 186 Acute basophilic leukemia (ABL) 188 Myeloid proliferations associated with Down syndrome 188 Transient abnormal myelopoiesis (TAM) 189 AMLs in patients with Down syndrome 189 Blastic plasmacytoid dendritic cell neoplasm (BPDCN/PDCL) 189 Acute leukemias with ambiguous lineage attribution (ALAL) 192 Acute undifferentiated leukemias (AUL) 192 Mixed phenotype acute leukemias (MPAL) 192 Neoplastic diseases of B and T lymphatic precursors 194 B lymphoblastic leukemia/lymphoma, not otherwise specified (B‐ALL/LBLnos) 195 B lymphoblastic leukemia/lymphoma with recurrent genetic anomalies 197 Relationships between genotype and phenotype in cases of B‐ALL not recognized as separate entities in WHO 2017 201 T lymphoblastic leukemia/lymphoma (T‐ALL/LBL) 202 Early T‐cell precursor lymphoblastic leukemia (ETP‐ALL) 205 NK lymphoblastic leukemia/lymphoma (NK‐ALL/LBL) 205 Neoplastic diseases of mature B cells 206 Chronic lymphocytic leukemia/small lymphocytic lymphoma (B‐CLL/SLL) 206 Familial B‐CLL 215 Richter syndrome 215 Monoclonal B‐cell lymphocytosis (MBL) 216 CLL‐like monoclonal B lymphocytosis 216 Non‐CLL‐like monoclonal B lymphocytosis 216 B‐cell prolymphocytic leukemia (B‐PLL) 216 Lymphoplasmacytic lymphoma (LPL) 218 Heavy chain disease (HCD) 221 γ heavy chain disease 222 μ heavy chain disease 222 α heavy chain disease 222 Hairy cell leukemia (HCL) 222 Hairy cell leukemia, variant (HCL‐v) 226 Hairy cell leukemia, Japanese variant (HCL‐J) 227 Splenic diffuse red pulp lymphoma (SDRPL) 227 Marginal zone lymphomas (MZL) 228 Nodal marginal zone lymphoma (NMZL) 229 Splenic marginal zone lymphoma (SMZL) 230 Extranodal marginal zone lymphoma (EMZL/MALToma) 232 Clonal B‐cell lymphocytosis with MZL‐like phenotype (CBL‐MZ) 233 Follicular lymphoma (FCL) 234 Testicular follicular lymphoma 237 Duodenal type follicular lymphoma 237 Pediatric type follicular lymphoma 237 Primitive cutaneous follicular lymphoma (PCFL) 237 Large B‐cell lymphoma with IRF4 rearrangement 237 Mantle‐cell lymphoma (MCL) 237 Blastic mantle‐cell lymphoma (BMCL) 240 Leukemic non nodal mantle‐cell lymphoma 240 DLBCL not otherwise specified (DLBCLnos) 240 CD5(+) diffuse large cell lymphoma (CD5(+) DLBCL) 243 T‐cell/histiocyte‐rich B‐cell lymphoma (THRLBCL) 243 Primary DLBCL of the CNS (PCNSL) 244 Primary cutaneous DLBCL, “leg type” 244 EBV(+) DLBCLnos 244 DLBCL associated with chronic inflammation (PAL) 245 Fibrin associated DLBCL 245 Lymphomatoid granulomatosis (LYG) 245 Primary mediastinal B‐cell lymphoma (PMBCL) 245 Intravascular large B‐cell lymphoma (IVBCL) 246 ALK‐positive large cell lymphoma (ALK(+) LBCL) 246 Plasmablastic lymphoma (PBL) 247 Primary effusion lymphoma (PEL) 247 HHV8‐associated lymphoproliferative disorders 247 HHV8‐positive DLBCL 248 HHV8‐positive germinotropic lymphoproliferative disorder 248 Burkitt lymphoma (BL) 248 Burkitt leukemia with immature phenotype 250 Burkitt‐like lymphoma with 11q aberrations 251 High‐grade B‐cell lymphoma (HGBL) 251 Plasma cell neoplasms 251 Monoclonal gammopathies of undetermined significance (MGUS) 253 Multiple myeloma (MM) 253 Plasma cell leukemia (PCL) 257 Neoplastic diseases of mature T and NK cells 258 T‐cell prolymphocytic leukemia (T‐PLL) 258 T‐cell large granular lymphocytic leukemia (T‐LGL) 261 Chronic lymphoproliferative disorders of NK cells (CLPD‐NK/CNKL) 263 Aggressive NK‐cell leukemia (ANKL) 266 Adult T‐cell leukemia/lymphoma (ATLL) 266 Extranodal NK/T-cell lymphoma, “nasal type” (ENKTL) 269 Intestinal T‐cell lymphomas (ITCL) 270 Enteropathy‐associated T‐cell lymphoma (EATCL) 270 Monomorphic epitheliotropic intestinal T‐cell lymphoma (MEITL) 272 Indolent gastro‐intestinal T lymphoproliferative disorder (indolent GI T‐LPD) 273 Hepatosplenic T‐cell lymphoma (HSTCL) 273 Subcutaneous panniculitis‐like T‐cell lymphoma (SPTCL) 275 Mycosis fungoides (MF) 275 Sezary syndrome (SS) 277 Primary cutaneous CD30(+) lymphoproliferative disorders 279 Lymphomatoid papulosis (LyP) 279 Primary cutaneous anaplastic T‐cell lymphoma (pcALCL) 279 Primary cutaneous peripheral T‐cell lymphoma (PTCL) 280 Primary cutaneous TCRγδ(+) T‐cell lymphoma (PCGD‐TCL) 280 Primary cutaneous CD8(+) aggressive epidermotropic cytotoxic T‐cell lymphoma (PCAETL) 280 Primary cutaneous acral CD8(+) T‐cell lymphoma (PCATCL) 280 Primary cutaneous lymphoma of the medium/small CD4(+) T cells (PCSM‐TCL) 281 Peripheral T‐cell lymphoma, not otherwise specified (PTCLnos) 281 Nodal lymphomas of follicular T‐helper derivation 283 Angioimmunoblastic T‐cell lymphoma (AITL) 283 Follicular T‐cell lymphoma (FTCL) 285 Nodal PTCL with follicular T‐helper phenotype 285 Anaplastic large cell lymphoma ALK(+) (ALCL ALK(+)) 285 Anaplastic large cell lymphoma ALK(‐) (ALCL ALK(‐)) 288 Breast implant–associated anaplastic large cell lymphoma (biaALCL) 288 Hodgkin lymphomas 289 Classic Hodgkin lymphoma (CHL) 289 Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) 290 Neoplastic diseases of histiocytic and dendritic cells 291 Histiocytic sarcoma (HS) 292 Langerhans cell histiocytosis (LCH) 292 Indeterminate dendritic cell tumor (IDCT) 292 Interdigitating dendritic cell sarcoma (IDCS) 292 Follicular dendritic cell sarcoma (FDCS) 292 Erdheim–Chester disease (EDC) 292 3 Appendix 293 Acute leukemias not recognized by the 2017 WHO classification 294 Acute leukemia of myeloid/NK precursors (M/NK‐AL) 294 Acute leukemia of myeloid dendritic cells (MDCL) 294 Acute leukemia of Langerhans cells 294 Composite lymphomas 294 Hypereosinophilic syndrome (HES), lymphocyte variant 295 Indolent T lymphoblastic proliferations (iT‐LBP) 295 Polyclonal lymphocytoses of B lymphocytes 298 Persistent polyclonal B‐cell lymphocytosis (PPBL) 298 Persistent polyclonal CD5(+) B‐cell lymphocytosis 298 Persistent polyclonal B‐cell lymphocytosis, Japanese (hairy) variant 298 Polyclonal plasmacytoses 299 Small round (blue) cell tumors (SR(B)CT) 300 References 301 Index 429

    3 in stock

    £141.26

  • Hematology Case Review

    Lippincott Williams and Wilkins Hematology Case Review

    Out of stock

    Book Synopsis Hematology Case Review is a comprehensive text that covers the expansive knowledge about the study of blood cells.After collecting blood smears and bone marrow aspirates for over 40 years, Dr. Doll has created the most up to date and comprehensive compilation of hematology case studies. These samples form the core of the case studies featured in this book, including benign disorders, such as hereditary spherocytosis, to neoplastic neoplasms like acute leukemia.Within the text, both rare and common conditions are discussed, with the presenting symptoms, blood counts, and pertinent images. The book is formatted in an interactive problem-based layout in order to enhance the question and answer features of the book. It is a widely applicable text that has been utilized for its practicality for over 15 years, and is becoming particularly important for general internists, family practice physicians, and hospitalists. Additionally, Hematology Case Review continuTrade ReviewThe wealth of practical information is a testament to the authors' tremendous experience in hematologic disorders. The real-world cases make the book especially interesting and informative. This is a valuable contribution to the field and an especially helpful review for hematology-oncology fellows." - Nitya Nathwani, M.D., City of Hope, on belaf of Doody's Review Service

    Out of stock

    £999.99

  • Radiology and Pathology Correlation of Bone

    Lippincott Williams and Wilkins Radiology and Pathology Correlation of Bone

    1 in stock

    Book Synopsis Confidently diagnose challenging musculoskeletal lesions with expert guidance. Radiology and Pathology Correlation of Bone Tumors: A Quick Reference and Review is a practical, hands-on clinical reference that helps you evaluate all of the diagnostic clues at your disposal to accurately identify the most frequently encountered benign and malignant bone tumors . Co-written by a radiologist and a pathologist, it shows you how to correlate radiography, scintigraphy, CT, MRI, PET, and PET-CT with gross pathology, histopathology, immunohistochemistry, and genetics to achieve maximum diagnostic certainty . This compact, high-yield resource is an ideal tool for quick look-upsin everyday practice as well as board review .Key FeaturesEasily review all the information you need about each lesion including a definition, epidemiology, sites of involvement, clinical findings, imaging characteristics, histopa

    1 in stock

    £158.39

  • Lippincott Williams and Wilkins Intraocular Tumors An Atlas and Textbook

    1 in stock

    Book Synopsis Selected as a Doody's Core Title for 2022 and 2023! For outstanding visual clarity in ocular diagnosis … nothing else comes close. In this updated and revised third edition, world-renowned authorities at the Wills Eye Hospital provide outstanding guidance on recognition, evaluation, and treatment of ocular tumors, highlighted by more than 2,500 stunning photographs and surgical drawings. This unsurpassed ocular oncology resource is a comprehensive guide to the clinical features, diagnosis, management, and pathology of intraocular tumors and pseudotumors, depicting clinical variations, treatment, and histopathologic characteristics of the many varied benign and malignant lesions that affect the uveal tract, retina, and other intraocular structures. Now brought thoroughly up to date with recent clinical and scientific innovations, this unique volume has been greatly expanded with over 25% new material, and offers more high-quality images than anyTrade Review"beautiful imaging, succinct descriptions, and sound clinical guidance ""a worthy and monumental undertaking" "online format will allow the busy clinician to more easily access its wisdom"" transcendent in that it is beneficial to all who have enlisted in the battle against ophthalmic and/or oncologic disease""Eyecare professionals at any level will appreciate its captivating images and concise explanations.""the most impressive collection of clinical images currently available in ocular oncology and, arguably, all of ophthalmology"Doody's Star Rating ®: 5 stars Score: 97-Doodys Publishers' Club, Friday, November 13, 2015

    1 in stock

    £288.00

  • Eyelid Conjunctival and Orbital Tumors An Atlas

    Lippincott Williams and Wilkins Eyelid Conjunctival and Orbital Tumors An Atlas

    1 in stock

    Book Synopsis Selected as a Doody's Core Title for 2022 and 2023! For outstanding visual clarity in ocular diagnosis … nothing else comes close. In this updated and revised third edition, world-renowned authorities from the Wills Eye Hospital provide outstanding guidance on recognition, evaluation, and treatment of ocular tumors, highlighted by more than 3,000 stunning photographs and surgical drawings. This unsurpassed ocular oncology resource is a comprehensive guide to the clinical features, diagnosis, management, and pathology of eyelid, conjunctival, and orbital tumors and pseudotumors, depicting clinical variations, treatment and histopathologic characteristics of the wide spectrum of neoplasms and related lesions. Now brought thoroughly up to date with recent clinical and scientific innovations, this unique volume offers more high-quality images than any other text/atlas in the field. Presents each entity in an easy-to-follow format: a concise

    1 in stock

    £291.59

  • Lippincott Williams and Wilkins Pediatric Radiation Oncology

    Out of stock

    Book Synopsis Selected as a Doody's Core Title for 2022 and 2023! BMA Medical Book Awards 2017?: Oncology – Highly Commended?The British Medical Association honored Pediatric Radiation Oncology, 6th Edition with this prestigious award.Pediatric Radiation Oncology, Sixth Edition continues to be the premier reference that offers comprehensive coverage of this challenging area for the radiation oncologist in training or practice, medical radiation physicists and dosimetrists, as well as pediatric oncologists and others interested in understanding childhood malignancies. This definitive text has been completely updated to reflect recent advances in the field. Manageable in size and engaging to read, it efficiently synthesizes data on pathogenesis, pathology, diagnostic workup, staging, treatment approaches (particularly radiation therapy—indications, doses, volumes, and treatment planning), and toxic outcomes, as well as guidance on decisTrade Review BMA Medical Book Awards 2017?: Oncology – Highly Commended?The British Medical Association honored Pediatric Radiation Oncology, 6th Edition with this prestigious award.Doody's Core Title (2017 Edition) 2.67 (Nursing - Oncology) 2.53 (Health Sciences - Radiation Oncology) Essential Purchase Title

    Out of stock

    £176.79

  • Lippincott Williams and Wilkins The Bethesda Review of Oncology

    2 in stock

    Book SynopsisPerfect for any clinician short on time who needs to practice for oncology board exams, The Bethesda Review of Clinical Oncology is from the same authors who brought you the trusted and bestselling Bethesda Handbook of Clinical Oncology . It’s packed with hundreds of disease-specific questions that are formatted just like an actual board review exam—so you can prep as effectively as possible and achieve test success. Features 500 review questions to help fellows and residents prepare for the American Board of Internal Medicine board review and MOC exams in medical oncology. Simulates an actual board review exam experience, with multiple-choice, single-best answer questions—and answer rationales—involving a hypothetical patient scenario. Aligns closely with content presented in the authors’ Bethesda Handbook of Clinical Oncology, also published by Lippincott Williams & Wilkins. Photos, illustraTrade Review“This fifth edition includes two new chapters, one on clinicalgenetics and one on diagnosis-driven individualization of cancer care, thatcover targeted therapy and personalized medicine, areas critical to today'spractice of oncology.This handbook is not intended to serve as an extensive and in-depth referencework, rather it is meant to be a comprehensive review of the management ofdifferent cancers including treatment regimens in a reader-friendly format.It is well suited for oncologists, medical students, residents,hematology/oncology fellows, oncology nurses, and, more broadly, anyoneinterested in gleaning concise information on the subject.This comprehensive review of more than 800 pages comprises 46 chapters devotedto various cancers, including both solid tumors and hematological malignancies.Despite the breadth, the book is designed for ready access to clinicallyrelevant information. To limit the size of the book, the authors place lesseremphasis on disease etiology, pathophysiology, and epidemiology and greateremphasis on practical considerations. Consistently, the endeavor combinesconcise and helpful information with plentiful illustrations, tables, andreferences. Chapter 46, on anticancer agents, is particularly impressive in itsdescription of the mechanism of action, approved indications, dosing,schedules, adverse reactions, and comments on a large number of cancer drugs.Written and edited by recognized experts from the National Cancer Institute,National Institutes of Health, and other leading research institutions, thiscomprehensive review is an outstanding resource.”Weighted Numerical Score: 100 - 5 Stars!Doodys Publishers' Club, June 2018

    2 in stock

    £68.39

  • Nova Science Publishers Inc Breast Cancer An Annotated Guide to the Current

    Out of stock

    Book Synopsis

    Out of stock

    £85.59

  • Hemostasis and Thrombosis: Basic Principles and

    Lippincott Williams and Wilkins Hemostasis and Thrombosis: Basic Principles and

    2 in stock

    Book SynopsisHemostasis and Thrombosis , Sixth EditionSince publication of the First Edition in 1982, Hemostasis and Thrombosis has established itself as the pre-eminent book in the field of coagulation disorders. No other book is as inclusive in scope, with coverage of the field from the standpoint of both basic scientists and clinicians. This comprehensive resource details the essentials of bleeding and thrombotic disorders and the management of patients with these and related problems, and delivers the most up-to-date information on normal biochemistry and function of platelets or endothelial cells, as well as in-depth discussions of the pharmacology of anticoagulant, fibrinolytic, and hemostatic drugs. NEW to the Sixth Edition…• A new team of editors , each a leader in his field, assures you of fresh, authoritative perspectives.• Full color throughout• A companion website that offers full text online and an image bank.• A new introductory section of chapters on basic sciences as related to the field• Entirely new section on Hemostatic and Thrombotic Disorders Associated with Systemic Conditions includes material on pediatric patients, women's health issues, cancer, sickle cell disease, and other groups.• Overview chapters preceding each section address broad topics of general importance.

    2 in stock

    £350.10

  • Manual for Radiation Oncology Nursing Practice

    Oncology Nursing Society Manual for Radiation Oncology Nursing Practice

    Out of stock

    Book SynopsisCaring for an individual receiving radiation therapy as part of overall cancer care requires a patient-focused approach. To support this patient population, nurses across treatment settings must constantly expand and refine their knowledge of advancements in radiation therapy technology, research, and evidence-based practice.In this fifth edition of the Oncology Nursing Society Manual for Radiation Oncology Nursing Practice and Education, nurses of all experience levels will advance their knowledge of radiation biology and protection, diverse radiation therapy modalities, combination treatments, site- and disease-specific issues, symptom management, special populations, and much more.This expanded and revised resource includes significant updates and additions to best reflect advancements in radiation oncology. New topics address patients with cognitive changes and dementia, general distress and coping, special populations including individuals with mental illness, special needs related to late effects of treatment and cardiac toxicities, and the latest treatment modalities. This manual will serve oncology nurses, advanced practice clinicians, educators, and administrators seeking the education and skills required to care for patients receiving radiation therapy and their families.

    Out of stock

    £999.99

  • Endometrial Cancer: Current Epidemiology,

    Nova Science Publishers Inc Endometrial Cancer: Current Epidemiology,

    1 in stock

    Book SynopsisThe purpose of this book is to provide a broad background of several aspects of basic sciences, clinical, therapeutic aspects, and management of endometrial cancer. It provides state-of-the-art information on the molecular genetics, biology, and clinical aspects of premalignant lesions of the endometrium and endometrial cancer. Also, the book chapters provide better understanding of the molecular and cellular events that underlie endometrial cancer. The descriptive and analytical epidemiology of endometrial cancer are presented in Chapter 1. The pathology and molecular diagnosis of endometrial cancer are discussed in Chapter 2. The molecular pathology of endometrial cancer is detailed in Chapter 3. The hereditary aspect of endometrial cancer is highlighted in Chapter 4. Precancerous lesions of the endometrium are reviewed in detail in Chapter 5. Endometrial biomarkers are detailed in Chapter 6. Lymphatic mapping of endometrial cancer is discussed in Chapter 7. Sentinel lymph nodes in endometrial cancer are highlighted in Chapter 8. The current strategies and approaches to treat patients with endometrial cancer are detailed in Chapter 9. Surgical techniques for endometrial cancer are reviewed in Chapter 10. The current treatment of advanced endometrial cancer is discussed in Chapter 11. Adjuvant medical therapeutic modalities are reviewed in Chapter 12. Targeted therapies for advanced endometrial cancer are presented in Chapter 13. The role of ErbB targeted therapy in treating endometrial cancer is discussed in Chapter 14. Finally, the quality of life of women with endometrial cancer is reviewed in Chapter 15. This book is intended for all clinicians and basic medical scientists caring for women with endometrial cancer, including attending surgeons and physicians, clinical fellows, and residents in the disciplines of gynecologic oncology, medical oncology, and surgical oncology, as well as PhD students and post-doctoral fellows in the basic medical sciences.

    1 in stock

    £163.19

  • Medical Physics Publishing Corporation Applied Physics for Radiation Oncology

    Out of stock

    Book SynopsisThe updated, second edition of the textbook Applied Physics for Radiation Oncology, originally published in 1996 is intended for both radiation therapists and students of radiation therapy. Chapters cover treatment planning, photon and electron dosimetry, brachytherapy, methods of dose calculation, isodose curves, beam-modifying devices, patient and beam geometry, radiation protection, and clinical use and operation of linear accelerators. The authors unify the principles of radiation therapy physics with the real world of clinical practice. A must for radiation therapists.Table of Contents Applied Physics for Radiation Oncology Acknowledgements Matter and Energy Matter Force Energy Radiation and Its Properties The Structure of an Atom Subatomic Particles Ionizing Radiation Linear Energy Transfer Electromagnetic Radiation Wave-Particle Duality Wavelength and Frequency The Production of X-Rays The Discovery of X-Rays Collision Interactions Characteristic Radiation Radiative Interactions (Bremsstrahlung) Filters Used in Conventional X-Ray Therapy Beam Direction as a Function of Incoming Electron Energy Beam Direction Dependency on X-Ray Target Design Radiation Quality X-Ray Intensity Beam Divergence Beam Attenuation Attenuation Coefficients 5. X-Ray and ?-Ray Interactions with Matter Attenuation Coefficients Coherent Scatter Photoelectric Effect Compton Effect Pair Production Pair Annihilation Photonuclear Interaction Energy Absorption Principles of Radiation Detectors Measurement of Radiation Gas Ionization Detectors How to Use a Survey Meter Scintillation Detectors Neutron Dosimeters Thermoluminescent Dosimeters Diode Detectors MOSFET Detectors Determining Radiation Intensity The Importance of Standardized Radiation Measurement The Roentgen as a Unit of Exposure Kerma "Conventional" X-Ray Machine Calibrations Radiation Absorbed Dose The fmedium Factor Cavity Theory Dose Equivalent Why Use Higher Energy Beams? Disadvantages of Low-Energy Machines Penumbra Size Inability to Use Isocentric Techniques Advantages of Megavoltage over Orthovoltage Beams Skin Sparing Electron Equilibrium Disadvantages of Megavoltage Linear Accelerators Accelerator Guides Waveguides Power Sources Bending Magnets The Raw Electron Beam X-Ray Beam Production X-Ray Beam Flattening Filters Photon Beam Collimation Electron Beam Production Electron Scattering Foils Electron Beam Collimation Monitor Chambers for Photon and Electron Beams Helical Technology The Linear Accelerator Console: The Operator Interface Quality Assurance Other High-Energy Machines Cobalt-60 Machines (Radionuclide Teletherapy) Timer Error Penumbra Quality Assurance of Cobalt-60 Machines Cyclotrons Heavy Particle Therapy The Geometry of Photon Beams Similar Triangles Magnification Abutting Fields Non-Midplane Structures Perpendiculars Planes Simple Beam Arrangements Isocentricity Conventional Beam Blocking Multileaf Collimation IMRT Photon Beam Dosimetry Dose and Distance Terms Dose Fractionation Quantities Used in Treatment Calculations Backscatter Factor Output Factor Equivalent Square Fields Equipment Attenuation Factors Patient Attenuation Factors Depth Dose Tissue-Air Ratio (TAR) Tissue-Maximum Ratio (TMR) Isodose Curves Dose Profiles Moving Field Calculations Computers Electron Beam Dosimetry Electron Beam Interactions Electron Beam Characteristics Electron Beam Profiles Gaps and Abutting Fields Electron Dose Measurements Treatment Calculations Irregularly Shaped Fields Tissue Inhomogeneities Inverse Square Law Treatment Planning Tumor Targeting Vocabulary Aims of Treatment Planning What Treatment Planning Includes Patient Alignment Devices Patient Positioning Aids Body Contours Isodose Distributions Oblique Incidence Corrections to Isodose Distributions Isodose Summations Treatment Techniques Stationary or Fixed Beam Treatment Moving Fields Treatment Tissue Inhomogeneities Tissue Compensation Wedge Filters Standard Treatment Calculation Beam On Time Calculations (Timer Settings) Monitor Unit Calculations Clinical Applications in Treatment Planning More Field Nomenclature Mixed Beams Tangents Field Weighting Normalization Non-Coplanar Beams Three-Dimensional Treatment Planning Conformal Methods IMRT IGRT Gated Radiation Therapy Brachytherapy Introduction Radium Radium Substitutes Radioactive Sources Applicators Afterloading Single Plane, Double Plane, and Volume Implants Permanent Implants Implant Dosimetry Remote High-Intensity Afterloading Specific Implant Techniques Radiation Safety with Implants Radiation Safety Recommendations and Regulations Measurement of Occupational Radiation Dose Radiation Risk Maximum Permissible Dose Equivalents Personnel Monitoring Time, Distance, and Shielding Radioactive Materials Radiation-Producing Machines Signs Appendix 1: Signs and Symbols Appendix 3: Glossary Appendix 5: Dosimetry Tables Appendix 7: The Elements Periodic Table Index

    Out of stock

    £93.60

  • Medical Physics Publishing Corporation The Physics and Applications of PET/CT Imaging

    Out of stock

    Book SynopsisCompiled from sessions presented at the 2008 AAPM Summer School, which was held June 25-27, 2008 at the Baylor College of Medicine, Texas Medical Center, Houston, TX. Topics include PET and CT basics, diagnostic and clinical alications, PET/CT scanner designs and characteristics, scanner testing, PET ACR accreditation and acceptance testing, PET/CT simulation for therapy alications, shielding calculations and radiation safety, and site planning.

    Out of stock

    £85.50

  • Wolters Kluwer Health Pizzo & Poplack's Pediatric Oncology

    1 in stock

    Book SynopsisSelected as a Doody's Core Title for 2022 and 2023! Comprehensive, authoritative, and up to date, Pizzo and Poplack’s Pediatric Oncology, 8th Edition, remains your most trusted source of information on the care and research of children with cancer. This award-winning text is the single most comprehensive reference on the biology and genetics of childhood cancer, its diagnosis and multimodal treatment, and long-term management. In the tradition of excellence established by Drs. Philip A. Pizzo and David G. Poplack, this 8th Edition keeps you fully informed while helping you collaborate more effectively with others on the cancer care team to enhance quality-of-life issues for patients and families. Covers all aspects of the breadth and depth of childhood cancer, including basic science, diagnostic tools, principles of treatment, and clinical trials, as well as highly detailed, definitive coverage of each pediatric malignancy. Includes updates to current treatment approaches based on the results of recently completed and published clinical research. Contains new information on the biology of pediatric malignancies and strategies for the conduct of clinical trials that reflect the rapid pace of laboratory discovery. Features chapters on palliative care and education, and covers supportive care in contexts such as emergencies, infectious disease, and nutrition. Provides expert guidance on state-of-the-art, multidisciplinary care for children and families, including psychosocial aspects of care and perspectives from patients and parents. Discusses the cooperative nature of pediatric oncology as a model for cancer research with information from cooperative clinical trial groups and consortia. Enrich Your eBook Reading Experience Read directly on your preferred device(s), such as computer, tablet, or smartphone. Easily convert to audiobook, powering your content with natural language text-to-speech.

    1 in stock

    £288.00

  • Berek and Hacker’s Gynecologic Oncology

    Wolters Kluwer Health Berek and Hacker’s Gynecologic Oncology

    7 in stock

    Book SynopsisSelected as a Doody's Core Title for 2022 and 2023! Evidence-based, superbly illustrated, and easy to read, Berek & Hacker’s Gynecologic Oncology, Seventh Edition, remains your reference of choice for authoritative information on every aspect of gynecologic malignancies. Templated chapters provide quick access to guidance on everything from general principles through diagnosis and medical and surgical management. This fully revised edition offers the practical, state-of-the-art coverage you need when caring for women with preinvasive disease; ovarian, breast, uterine, cervical, vulvar, and vaginal cancers; and gestational trophoblastic disease. All chapters have been carefully updated to reflect the most current literature and practice recommendations. Presents summaries on signs and symptoms, staging, treatment, relevant basic science, genetics, and molecular issues. Key topics include preoperative care, laparoscopy, robotics, nutritional therapy, cancer in pregnancy, surgical techniques, symptom relief, and palliative care. Includes new chapters on genetics; cancer cell biology; and biologic, targeted, and immune therapies, as well as completely rewritten chapters on chemotherapy and communication skills. Features a new, visually appealing two-column design similar to Berek & Novak’s Gynecology, 16th Edition. Helps you visualize key concepts with full-color illustrations and drawings, pathology slides, and clinically relevant diagrams. Presents the knowledge and expertise of global leaders in gynecologic oncology, keeping you at the forefront of your field and preparing you for board exams. Clearly translates basic science to clinical practice, making it an excellent everyday resource for gynecologic oncologists and fellows, general gynecologists, and medical and radiation oncologists. Enrich Your eBook Reading Experience Read directly on your preferred device(s), such as computer, tablet, or smartphone. Easily convert to audiobook, powering your content with natural language text-to-speech.

    7 in stock

    £144.00

  • Oncology Rapid Review Flash Cards

    Wolters Kluwer Health Oncology Rapid Review Flash Cards

    2 in stock

    Book SynopsisFace the oncology board exam with confidence! Oncology Rapid Review, created and edited by Drs. Utkarsh H. Acharya and Tejaswini Dhawale, is a conveniently portable, effective review tool that helps you prepare for this comprehensive and challenging exam. Sturdy, full-color flash cards provide a focused, case-based review anytime, anywhere. Over 500 cards, 6” x 4”, illustrated in full color. Card front asks either clinical case or case-independent high-yield questions. Card back provides the correct answer and rationale. Expertly authored topics include American Board of Internal Medicine (ABIM) Medical Oncology Certification blueprint-based content spanning from therapeutics to a wide spectrum of neoplastic disorders. Enrich Your eBook Reading Experience Read directly on your preferred device(s), such as computer, tablet, or smartphone. Easily convert to audiobook, powering your content with natural language text-to-speech.

    2 in stock

    £70.68

  • DeVita, Hellman, and Rosenberg's Cancer

    Wolters Kluwer Health DeVita, Hellman, and Rosenberg's Cancer

    7 in stock

    Book SynopsisBased on DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology, Eleventh Edition, this comprehensive review book covers the entire specialty of oncology, including new or expanded coverage of molecular biology; epidemiology and etiology; screen and prevention; genetics; clinical trials; and immunotherapy. Inside, readers will discover hundreds of multiple-choice and case-based questions, along with detailed answers and explanations to help explain the how and why behind each correct response. The ideal way to maximize exam scores for today’s student and residents!Learning and review features include: Hundreds of multiple-choice and case-based questions to build comprehension and improve retention. All topics cross-referenced to the latest edition of DeVita, Hellman, and Rosenberg’s Cancer: Principles & Practice of Oncology, Eleventh Edition. Material on all aspects of oncology, including medical, radiation and surgical oncology, as well as hematology/oncology issues Enrich Your eBook Reading Experience Read directly on your preferred device(s),such as computer, tablet, or smartphone. Easily convert to audiobook,powering your content with natural language text-to-speech.

    7 in stock

    £72.00

  • Jaypee Brothers Medical Publishers Regional Therapeutics for Advanced Malignancies

    Out of stock

    Book SynopsisRegional Therapeutics for Advanced Malignancies is a concise guide to treatment of cancer in different parts of the body. Divided into four sections, this book covers peritoneal disease; gynaecological malignancies; melanoma, sarcoma and lung; and liver. Each section discusses different treatments that may be used to treat cancer within that part of the body. Authored by recognised specialists in the UK and USA, this manual contains more than 120 colour images and illustrations. Key Features Concise guide to treatment of cancer in different regions of the body Covers peritoneal disease, gynaecological malignancies, melanoma, sarcoma and lung; and liver Each section discusses different treatment options for that region Recognised authors from UK and USA More than 120 colour images and illustrations Table of ContentsSection 1: Peritoneal Disease Pathophysiology of Peritoneal Malignancies and Modalities of Treatment Pseudomyxoma Peritonei and Peritoneal Mucinous Carcinoma of Appendiceal Origin Carcinomatosis from Colon Cancer Malignant Peritoneal Mesothelioma (MPM) Section 2: Gynecological Malignancies Intraperitoneal Chemotherapy for Ovarian Cancer Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Ovarian Cancer Section 3: Melanoma, Sarcoma and Lung Isolated Limb Perfusion (ILP) and Isolated Limb Infusion (ILI) for Locally Advanced Malignant Melanoma Isolated Limb Perfusion for Extremity Sarcoma Hyperthermic Intrathoracic Chemotherapy Thermal Ablation of Lung Tumors and Pulmonary Metastases Section 4: Liver Hepatic Arterial Infusion Pumps Hepatic Arterial Therapies for Colorectal Liver Metastases Ablations RFA vs Microwave vs Other Isolated Hepatic Perfusion with TNF and Melphalan for Patients with Diffuse Hepatic Metastases Index

    Out of stock

    £62.70

  • Elsevier - Health Sciences Division Head and Neck Cancers An Issue of PET Clinics

    Out of stock

    Book SynopsisTable of ContentsClinical Role of Positron Emission Tomography/Computed Tomography Imaging in Head and Neck Squamous Cell Carcinoma PET Imaging of Oral Cavity and Oropharyngeal Cancers PET/Computed Tomography: Laryngeal and Hypopharyngeal Cancers 18F-fluorodeoxyglucose PET/Computed Tomography: Head and Neck Salivary Gland Tumors Positron Emission Tomography/Computed Tomography in Thyroid Cancer PET/CT: Nasopharyngeal Cancers PET/CT: Radiation Therapy Planning in Head and Neck Cancer 2-Deoxy-2-[18F] Fluoro-D-Glucose PET/Computed Tomography: Therapy Response Assessment in Head and Neck Cancer PET/Computed Tomography: Post-therapy Follow-up in Head and Neck Cancer

    Out of stock

    £46.49

  • Aesthetic Treatments for the Oncology Patient

    Taylor & Francis Ltd Aesthetic Treatments for the Oncology Patient

    15 in stock

    Book SynopsisPhysicians are increasingly recognizing that helping a cancer patient feel good about themselves and about their appearance can be of vital importance in giving them the emotional support and psychological resilience to survive and recover from the side-effects of disease and its treatment. Dermatologists and other aesthetic physicians are in a prime position to help a cancer patient recover lost volume, hydration, and pigmentation in skin, nails, and hair, as well as to advise on nutrition, prostheses, and complentary therapies. This pioneering volume will be an important resource bringing together the expertise in this area, with the practical detail a physician will need.Table of Contents1. The oncologic patient and aesthetic medicine: The bonded approach. 2. Challenges for oncology: Prevention, palliation, and survival. 3. Cancer as a chronic disease. 4. Clinical record: Oncological screening. 5. Tumor markers. 6. The psychological approach: The healing power of image and comprehensive assistance to cancer patients. 7. The role of the family. 8. The oncological patient environment: Legal framework and ethics. 9. Radiotherapy: The prevention of secondary effects, radiodermatitis, and long-term toxicity. 10. Prevention and treatment of dermatological secondary effects of cancer therapy. 11. Prevention and treatment of adverse effects of antineoplastic therapy and of delayed-onset side effects: Prevention and treatment of hair loss. 12. Melatonin for prevention and treatment of complications associated with chemotherapy and radiotherapy: Implications for cancer stem cell differentiation. 13. Chronic antineoplastic therapies and their impact on quality of life. 14. Interactions with medical-aesthetic treatments. 15. Medical-aesthetic treatments in the survivor patient. 16. Medical aesthetic treatments in oncology patients. 17. Facial medical-aesthetic treatments in oncology patients. 18. Filler materials: Indications, contraindications, and special considerations in oncology patients. 19. Aesthetic-medical treatments during disease: What is the plan? 20. The role of the aesthetic doctor in the follow-up of the oncology patient. 21. Medico-aesthetic collaboration. 22. Dietetics and nutrition in oncology patients: Evaluation of the nutritional status, weight control, and nutrigenomics. 23. Nutrition: Diet therapy and nutritional supplements. 24. Introduction to vascular complications in oncology patients. 25. Anatomy of lymphatic drainage of the limbs. 26. Prevention and treatment of secondary lymphedema of extremities, early diagnosis of lymphostasis, and postsurgical prevention and conservative treatment of lymphedema. 27. Prevention and treatment of venous thromboembolism. 28. Cosmetic-medical treatments. 29. Micropigmentation applied to oncology patients. 30. Photoprotection in oncology patients. 31. Scar care after surgical treatment in oncology patients. 32. Cancer and physical exercise. 33. Ozone therapy in oncology patients. 34.Thermal treatments in postcancer care.

    15 in stock

    £170.00

  • Taylor & Francis Ltd Basic Clinical Radiobiology

    Out of stock

    Book SynopsisBasic Clinical Radiobiology is a concise but comprehensive textbook setting out the essentials of the science and clinical application of radiobiology for those seeking accreditation in radiation oncology, clinical radiation physics, and radiation technology.Fully revised and updated to keep abreast of current developments in radiation biology and radiation oncology, this fifth edition continues to present in an interesting way the biological basis of radiation therapy, discussing the basic principles and significant developments that underlie the latest attempts to improve the radiotherapeutic management of cancer.This new edition is highly illustrated with attractive 2-colour presentation and now includes new chapters on stem cells, tissue response and the convergence of radiotherapy, radiobiology, and physics. It will be invaluable for FRCR (clinical oncology) and equivalent candidates, SpRs (and equivalent) in radiation oncology, practicing radiaTrade Review"...a valuable resource for more clinically minded individuals needing to know the basics of tissue and tumor response to a variety of radiation regimens."Robert J Griffin, PhD (University of Arkansas for Medical Sciences)Table of ContentsIntroduction: The significance of radiobiology and radiotherapy for cancer treatment. Irradiation-induced damage and the DNA damage response. Cell death after irradiation: How, when and why cells die. Quantifying cell kill and cell survival. Radiation dose-response relationships. Linear energy transfer and relative biological effectiveness. Physics of radiation therapy for the radiobiologist. Tumour growth and response to radiation. Fractionation: The linear-quadratic approach. The linear-quadratic approach in clinical practice. Modified fractionation. Time factors in normal tissue responses to irradiation. The dose-rate effect. Pathogenesis of normal tissue side effects. Stem cells in radiotherapy. Normal tissue tolerance and the effect of dose inhomogeneities. The oxygen effect and therapeutic approaches to tumour hypoxia. The tumour microenvironment and cellular hypoxia responses. Combined radiotherapy and chemotherapy. Molecular targeted agents for enhancing tumour response. Biological individualisation of radiotherapy. Molecular image guided radiotherapy. Retreatment tolerance of normal tissues. Biological response modification of normal tissue reactions: Basic principles and pitfalls. Hadron therapy: The clinical aspects. Tissue response models. Second cancers after radiotherapy.

    Out of stock

    £66.49

  • Diseases of the Breast 5e

    Lippincott Williams and Wilkins Diseases of the Breast 5e

    2 in stock

    Book SynopsisExpand your knowledge of every aspect of breast diseases. This book is designed to foster the understanding necessary to provide optimal patient care. It is suitable for clinician seeing patients with breast disease, especially carcinoma of the breast.Trade Review4 STAR REVIEW!"This is an excellent reference for fellows and other clinicians caring for patients with breast disease. Its main advantages over similar books are the breadth of coverage as well as the quality of information and analysis. The previous edition was published four years ago, a long time in the rapidly changing field of breast oncology, and this new edition is certainly warranted." - Ingrid M Lizarraga, MBBS, University of Iowa Hospitals and Clinics, on behalf of Doody's Review

    2 in stock

    £298.79

  • Fitzness International LLC My Noisy Cancer Comeback: Running at the Mouth,

    Out of stock

    Book Synopsis

    Out of stock

    £999.99

  • Drug Development for Cancer and Diabetes: A Path

    Apple Academic Press Inc. Drug Development for Cancer and Diabetes: A Path

    Out of stock

    Book SynopsisKey features include: Details the role of plants for the treatment and management of cancer and diabetes Discusses the role of phytocompounds as ligands for cancer and diabetic targets Reviews plants and the potential of phytochemicals as antidiabetic and anticancer drugs Explores the green biosynthesis of nanoparticles and their treatment efficiency Trade Review“This book extrapolates the recent advancements, emerging trends, and novel innovations and speculates about the future perspective in the discovery of drugs for the treatment of cancer and diabetes. As a complete package for the readers, this book provides a valuable window on the revolutionary sector of drug discovery. Part I and Part II of the book together provides comprehensive content to understand the theoretical aspect as well as practical advances and research discoveries. The novel approach of depicting the role of plants and the potential of phytochemi¬cals as antidiabetic and anticancer drugs is a key feature.”—From the Foreword by Dr. P. Padmanabhan, Deputy Director, Lee Kong Chian School of Medicine, Nanyang Technological University, SingaporeTable of ContentsPART I CANCER AND LEADS FOR CANCER TREATMENT 1. Biomarkers for Screening of Premalignant Lesions and Therapeutic Surveillance 2. Kinase Targets in Cancer Drug Discovery 3. Essential Drug Properties and Stages in Anti-Cancer Drug Development 4. Plant Constituent as Anti-Cancer Drugs 5. Anticancer Properties of Some Effective Phytochemicals 6. Therapeutic Aspects of Some Extracts and Purified Cardiac Glycosides Obtained From Nerium oleander L 7. Challenging Compounds of Some Medicinal Plants Against Cancer 8. Medicinal Plants as Therapeutic Agents in the Treatment of Cancer 9. Cytotoxic, Apoptosis Inducing Effects and Anti-Cancerous Drug Candidature of Jasmonates 10. Apoptosis Activity of 1,2,-Benzene Dicarboxylic Acid Isolated from Andrographis paniculata on KB, SiHa and IMR Cancer Cell Line 11. Anticancer Drug Discovery From the Indian Spice Box 12. Phytochemical Investigation and Evaluation of Anti-Breast Cancer Activity of Chloroform Extract of Tagetes erecta 13. Isolation, Identification and In Silico Evaluation of Anticancer Activity of Flavone from Pisum sativum 14. Functional Lead Phytochemicals from the Rutaceae and Zingeiberaceae Plants for Development of Anticancer Drugs 15. In Vitro Anticancer Activity of Biophytum sensitivum on Liver Cancer Lines (HEPG2) 16. Saffron and Its Active Ingredients: A Natural Product with Potent Anticancer Property PART I: ANTIDIABETIC DRUG DISCOVERY 17. Effects of Pterocarpus marsupium in the Management of Type 2 Diabetes Mellitus 18. Antidiabetic and Antihyperlipidemic Activities of Cyathea nilgiriensis (Holttum) on STZ Induced Diabetic Rats 19. Antidiabetic Activity of Drug Loaded Chitosan Nanoparticle 20. Antidiabetic Activity of Silver Nanoparticles Biosynthesized Using Ventilago maderaspatana Leaf Extract 21. Hypoglycemic Activity of Biophytum sensitivum Whole Plant Extracts on Alloxan Induced Diabetic Rats 22. Antidiabetic Activity of Ventilago maderaspatana Leaf Extracts on STZ Induced Diabetic Rats 23. Isolation, Identification, and Molecular Docking of Antidiabetic Compounds of Cyatheia nilgiriensis (Holttum) 24. Antidiabetic Potentials of Major Indian Spices: A Review 25. Aloe Species: Chemical Composition and Therapeutic Uses in Diabetic Treatment

    Out of stock

    £78.84

  • IntechOpen Translational Research in Cancer

    Out of stock

    Book SynopsisTranslational research in oncology benefits from an abundance of knowledge resulting from genome-scale studies concerning the molecular pathways involved in tumorigenesis. Translational oncology represents a bridge between basic research and clinical practice in cancer medicine. The vast majority of cancer cases are due to environmental risk factors. Many of these environmental factors are controllable lifestyle choices. Experimental cancer treatments are studied in clinical trials to compare the proposed treatment to the best existing treatment through translational research. The key features of the book include: 1) New screening for the development of radioprotectors: radioprotection and anti-cancer effect of β-Glucan (Enterococcus faecalis) 2) Translational perspective on hepatocellular carcinoma 3) Brachytherapy for endometrial cancer 4) Discovery of small molecule inhibitors for histone methyltransferases in cancer

    Out of stock

    £89.25

  • Dandelion Digital Well Done Me

    Out of stock

    Book Synopsis

    Out of stock

    £999.99

  • HarperCollins Publishers Inc Fatal to Fearless

    10 in stock

    Book Synopsis

    10 in stock

    £20.00

  • Elsevier Science Publishing Co Inc Malignant Pleural Mesothelioma

    Out of stock

    Book SynopsisTable of Contents1. Epidemiology and surveillance evidence2. Multimodality Imaging assessment of Malignant Pleural Mesothelioma3. Surgery of Malignant Pleural Mesothelioma4. Diagnostic pathology of Malignant Pleural Mesothelioma: cytological, histological, immunohistochemical features5. Molecular mechanisms in the pathogenesis of Malignant Pleural Mesothelioma: predictive and prognostic factors6. The treatment of Malignant Pleural Mesothelioma: from the current standard to novel possible therapeutic strategies7. Future directions in Malignant Pleural Mesothelioma: an overview of the expert opinion

    Out of stock

    £97.75

  • Cancer on Trial

    The University of Chicago Press Cancer on Trial

    1 in stock

    Book SynopsisUntil the early 1960s, cancer treatment consisted of surgery and radiation therapy. Most practitioners then viewed the treatment of terminally ill cancer patients with heroic courses of chemotherapy as highly questionable. This title explores how practitioners established a style of practice, at the center of which lies the clinical cancer trial.Trade Review"This remarkable book charts the emergence of a clinical field - medical oncology - for which experimental protocols have become routinized as a form of normal practice. Cancer on Trial will make a lasting contribution to the sociology of scientific knowledge, the history of clinical practice, and the understanding of the networked basis of biomedical research." (Jeremy A. Greene, Harvard University)"

    1 in stock

    £76.00

  • The Cure  A Story of Cancer  Politics from the

    The University of Chicago Press The Cure A Story of Cancer Politics from the

    1 in stock

    Book SynopsisDid America try to steal Soviet cancer secrets? And how could a cancer cure turn into a biological atom bomb? This tale of scientific discovery and politics investigates the ideological wrangling and conflicts within the Cold War search for a cure for cancer.Trade Review"A fascinating and seductively accessible account of medical science in Stalin's Russia, of the quest for a cure for cancer in the context of Cold War ideology, bureaucratic infighting, and disciplinary rivalries." - Charles Rosenberg, Harvard University

    1 in stock

    £25.00

  • Diet Nutrition and Cancer

    National Academies Press Diet Nutrition and Cancer

    Out of stock

    Book SynopsisTable of Contents1 Front Matter; 2 OVERVIEW AND MAJOR RECOMMENDATIONS; 3 APPROACH TO THE STUDY; 4 DIET AND THE MECHANISMS OF CARCINOGENESIS; 5 EPIDEMIOLOGICAL METHODS; 6 LABORATORY METHODS; 7 MACROCONSTITUENTS; 8 VITAMINS, MINERALS, AND NONNUTRITIVE INHIBITORS OF CARCINOGENESIS; 9 FOOD ADDITIVES, CONTAMINANTS, CARCINOGENS, AND MUTAGENS; 10 CONSUMER BEHAVIOR; 11 REFERENCES; 12 APPENDICES; 13 APPENDIX A: COMMITTEE ON DIET, NUTRITION, AND CANCER--AFFILIATIONS AND MAJOR RESEARCH INTERESTS; 14 APPENDIX B: ACKNOWLEDGEMENTS

    Out of stock

    £39.78

  • Practical Radiation Oncology Physics

    Elsevier - Health Sciences Division Practical Radiation Oncology Physics

    Out of stock

    Book SynopsisTrade Review"This comprehensive book closes the gap between the textbook and clinical practice. It answers the questions that physicists might initially have when trying to implement a new program, a new procedure, etc. The book will be a great reference for medical physics residents and junior physicists, as well as for physicists who are about to implement a new procedure. Medical residents can use the book to gain insights into the physics aspects of treatments. The authors have managed to distill the most important, currently available information to create a truly practical book on radiation oncology physics. This will be a valuable book for the radiation oncology team." -Sotirios Stathakis, PhD (University of Texas Health Sciences Center at San Antonio) Doody's Score: 98 - 5 StarsTable of ContentsPART I Building Blocks 1. Reference dosimetry for ionizing radiation 2. Relative dosimetry for MV beams 3. In-vivo dosimetry 4. Quality assurance and commissioning of new radiotherapy technology 5. Quality assurance of radiotherapy dose calculations 6. Immobilization techniques in radiotherapy 7. Image guidance and localization technologies for radiotherapy 8. Brachytherapy 9. Proton radiotherapy 10. Radiation safety and shielding in radiotherapy 11. Information Technology in Radiation Oncology 12. Quality and safety improvement in radiation oncology PART II Clinical Applications 13. Simulation for radiotherapy treatment planning 14. Treatment planning quality metrics 15. The use of electrons for external beam radiotherapy 16. IMRT and VMAT 17. SRS and SBRT 18. Clinical aspects of image guidance and localization in radiotherapy 19. Respiratory motion management for external beam radiotherapy 20. Intracavitary Brachytherapy 21. Interstitial Brachytherapy 22. Prostate seed implant 23. Intraoperative radiotherapy (IORT) 24. Special Procedures Appendix I Resource Documents Appendix II Glossary

    Out of stock

    £79.37

  • Hoffman and Abeloffs HematologyOncology Review

    Elsevier - Health Sciences Division Hoffman and Abeloffs HematologyOncology Review

    Out of stock

    Book SynopsisTable of ContentsIsaacs: Hoffman and Abeloff's Hematology-Oncology Review 1. Cancer biology and Genomics 2. Tumor Immunology 3. Anti-Cancer Therapies SECTION 1: Chemotherapy SECTION 2: Immunotherapy, antibodies, vaccines and pathway inhibitors 4. Clinical Trial Design and Ethics 5. Hereditary Cancer Syndromes HEMATOLOGIC MALIGNANCIES 6. Acute Myeloid Leukemia and Myelodysplastic Syndrome 7. Myeloproliferative Disorders 8. Chronic Lymphocytic Leukemia, Hairy Cell Leukemia, and other Chronic Lymphoproliferative Disorders 9: Hodgkin lymphoma 10. Non-Hodgkin Lymphoma 11. Multiple myeloma and other plasma cell dyscrasias 12. T cell and NK cell neoplasms and other lymphoid malignancies 13. Hematopoeietic Cell Transplantation SOLID TUMOR MALIGNANCIES 14. Breast cancer a: Early Stage Breast Cancer b: Metastatic breast cancer e. Premalignant breast conditions and in situ disease 15. Lung Cancer a: Non-small cell lung cancer b: Small cell lung cancer 16. Other Thoracic Malignancies a: Mesothelioma b: Thymoma and thymic cancer 17. Head and Neck cancer 18 : Esophageal Cancer 19: Gastric cancer 20: Pancreatic cancer 21: Colorectal cancer and Anal Cancer 22: Hepatobiliary cancer 23: Neuroendocrine, small bowel and appendiceal malignancies 24. Prostate cancer 25. Bladder and other urothelial cancers 26. Renal Carcinomas 27. Germ cell tumors 28. Gynecological Malignancies Ovarian Cancer and Fallopian Tube Cancer Cancer of the Cervix, Uterus, Vagina, Vulva and Gestational Choriocarcinoma 29. Melanoma and other skin cancers 30. Bone and soft tissue sarcoma 31.Cancer of unknown primary site 32. . Malignancies of the Central Nervous System a. Primary b. Metastatic NONMALIGNANT HEMATOLOGIC CONDITIONS 33. Coagulation 34. Hematopoietic System 1: Hematopoietic System Disorders RBC or iron 35. Transfusion Medicine SURVIVORSHIP AND END OF LIFE CARE Chapter 36. Supportive Care

    Out of stock

    £999.99

  • Abeloffs Clinical Oncology

    Elsevier - Health Sciences Division Abeloffs Clinical Oncology

    Out of stock

    Book SynopsisTable of ContentsAbeloff's Clinical Oncology Sixth Edition PART I: SCIENCE AND CLINCIAL ONCOLOGY SECTION A: BIOLOGY AND CANCER 1. Molecular Tools in Cancer Research 2. Intracellular Signaling 3. The Cellular Microenvironment and Metastases 4. Control of the Cell Cycle 5. The Pathophysiology of Cancer Cell Death 6. Cancer Immunology 7. Stem Cells, Cell Differentiation, and Cancer 8. Vascular and Interstitial Biology of Tumors 9. Cancer Metabolism SECTION B: GENESIS OF CANCER 10. Environmental Factors 11. DNA Damage Response Pathways and Cancer 12. Viruses and Human Cancer 13. Genetic Factors: Hereditary Cancer Predisposition Syndromes 14. Genetic and Epigenetic Changes in Cancer SECTION C: DIAGNOSIS OF CANCER 15. Pathology, Biomarkers, and Molecular Diagnostics 16. Imaging SECTION D: CLINICAL TRIALS 17. Biostatistics and Bioinformatics in Clinical Trials 18. Trial Design 19. Structures Supporting Cancer Clinical Trials 20. Oncology and Health Care Policy SECTION E: PREVENTION AND EARLY DETECTION 21. Discovery and Characterization of Cancer Genetic Susceptibility Alleles 22. Lifestyle and Cancer Prevention 23. Cancer Screening and Early Detection 24. Nicotine Dependence: Current Treatments and Future Directions SECTION F: TREATMENT 25. Cancer Pharmacology 26. Therapeutic Targeting of Cancer Cells: Era of Molecularly Targeted Agents 27. Basics of Radiation Therapy 28. Hematopoietic Stem Cell Transplantation 29. Gene Therapy in Oncology 30. Therapeutic Antibodies and Immunologic Conjugates 31. Complementary and Alternative Medicine PART II: PROBLEMS COMMON TO CANCER AND THERAPY SECTION A: HEMATOLOGIC PROBLEMS AND INFACTIONS 32. Disorders of Blood Cell Production in Clinical Oncology 33. Diagnosis, Treatment, and Prevention of Cancer-Related Venous Thrombosis 34. Infection in the Patient with Cancer SECTION B: SYMPTOM MANAGEMENT 35. Hypercalcemia 36. Tumor Lysis Syndrome 37. Cancer-Related Pain 38. Cancer Cachexia 39. Nausea and Vomiting SECTION C: TREATMENT COMPLICATIONS 40. Oral Complications 41. Dermatologic Toxicities of Anticancer Therapy 42. Cardiovascular Effects of Cancer Therapy 43. Reproductive Complications 44. Paraneoplastic Neurologic Syndromes 45. Neurologic complications 46. Endocrine Complications 47. Pulmonary Complications of Anticancer Treatment SECTION D: POST TREATMENT CONSIDERATIONS 48. Rehabilitation of Individuals with Cancer 49. Survivorship 50. Second Malignant Neoplasms 51. Caring for Patients at the End of Life SECTION E: LOCAL EFFECTS OF CANCER AND ITS METASTASIS 52. Acute Abdomen, Bowel Obstruction, and Fistula 53. Superior Vena Cava Syndrome 54. Spinal Cord Compression 55. Brain Metastases and Neoplastic Meningitis 56. Bone Metastases 57. Lung Metastases 58. Liver Metastases 59. Malignancy-Related Effusions SECTION F: SPECIAL POPULATIONS 60. Cancer in the Elderly: Biology, Prevention, and Treatment 61. Special Issues in Pregnancy 62. Human Immunodeficiency Virus (HIV) Infection and Cancer PART III: SPECIFIC MALIGNANCIES SECTION A 63. Cancer of the Central Nervous System SECTION B 64. Ocular Tumors 65. Cancer of the Head and Neck SECTION C: SKIN 66. Melanoma 67. Nonmelanoma Skin Cancers: Basal Cell and Squamous Cell Carcinomas SECTION D: ENDOCRINE 68. Cancer of the Endocrine System SECTION E: THORACIC 69. Cancer of the Lung: Non-Small Cell Lung Cancer and Small Cell Lung Cancer 70. Diseases of the Pleura and Mediastinum 71. Cancer of the Esophagus and Gastroesophageal Junction SECTION F: GASTROINTESTINAL 72. Cancer of the Stomach and Gastroesophageal Junction 73. Cancer of the Small Bowel 74. Colon Cancer 75. Cancer of the Rectum 76. Cancer of the Anal Canal 77. Liver and Bile Duct Cancer 78. Carcinoma of the Pancreas SECTION G: GENITOURINARY 79. Cancer of the Kidney 80. Carcinoma of the Bladder 81. Prostate Cancer 82. Cancer of the Penis 83. Testicular Cancer SECTION H: GYNECOLOGICAL 84. Cancers of the Cervix, Vulva, and Vagina 85. Cancer of the Endometrium 86. Ovaries and Fallopian Tubes 87. Gestational Trophoblastic Disease 88. Cancer of the Breast SECTION I: SARCOMAS 89. Sarcomas of Bone 90. Sarcomas of Soft Tissue SECTION J 91. Carcinoma of Unknown Primary SECTION K: PEDIATRICS 92. Pediatric Solid Tumors 93. Childhood Leukemia 94. Childhood Lymphoma SECTION L: HEMATOLOGICAL 95. Acute Leukemias in Adults 96. Myelodysplastic Syndromes 97. Myeloproliferative Disorders 98. Chronic Myeloid Leukemia 99. Chronic Lymphoid Leukemias 100. Hairy Cell Leukemia 101. Multiple Myeloma and Related Disorders 102. Hodgkin's Lymphoma 103. Non-Hodgkin Lymphoma 104. Cutaneous T-Cell Lymphoma and Cutaneous B-Cell Lymphoma 105. Adult T-Cell Leukemia-Lymphoma

    Out of stock

    £999.99

  • Practical Soft Tissue Pathology A Diagnostic

    Elsevier - Health Sciences Division Practical Soft Tissue Pathology A Diagnostic

    Out of stock

    Book SynopsisTrade Review"this book belongs at the bookshelf (and tablet) of any pathologist getting acquainted with the systematic approach to the complex world of soft tissue tumours." This book belongs at the bookshelf (and tablet) of any pathologist getting acquainted with the systematic approach to the complex world of soft tissue tumours. "This excellent book could be considered as one of the key references in soft tissue pathology. It is a particularly excellent resource for pathology residents or fellows who are seeking a comprehensive but concise book on soft tissue pathology." Kyle Perry, MD (Henry Ford Health Systems) Doody's Score: 100-5 Stars!Table of Contents1. Introduction: Tumor Classification and Immunohistochemistry 2. Biologic Potential, Grading, Staging, and Reporting of Sarcomas 3. Spindle Cell Tumors of Adults 4. Pediatric Spindle Cell Tumors 5. Tumors with Myxoid Stroma 6. Epithelioid and Epithelial-like Tumors 7. Pleomorphic Sarcomas 8. Round Cell Tumors 9. Biphasic Tumors and Tumors with Mixed Patterns 10. Soft Tissue Tumors with Prominent Inflammatory Cells 11. Giant Cell-Rich Tumors 12. Adipocytic Tumors 13. Vascular Tumors 14. Cartilaginous and Osseous Soft Tissue Tumors 15. Cutaneous Mesenchymal Tumors 16. Mesenchymal Tumors of the Gastrointestinal Tract 17. Lower Genital Soft Tissue Tumors 18. Applications of Molecular Testing to Differential Diagnosis

    Out of stock

    £999.99

  • IASLC Thoracic Oncology

    Elsevier - Health Sciences Division IASLC Thoracic Oncology

    Out of stock

    Book SynopsisTrade Review"Overall, this is an outstanding resource that everyone interested in this subject must have.. The main objective of this book and the well-thought-out content sets it apart from any other book in the same space." Reviewed by Ravi Salgia, MD, PhD (City of Hope) Doody's Score: 98, 5 Stars!Table of ContentsSection 1: Lung Cancer Control and Epidemiology 1. Classical Epidemiology 2. Tobacco Control and Primary Prevention 3. Tobacco Cessation 4. Non-Smoking Related Lung Cancer 5. Gender-Related Differences in Lung Cancer 6. Genetic Susceptibility to Lung Cancer 7. Early Detection and Radiologic Screening 8. Preclinical Biomarkers for The Early Detection of Lung Cancer 9. Chemoprevention of Lung Cancer: Present and Developing Technologies Section 2: Lung Cancer Molecular Carcinogenesis 10. Copy Number Abnormalities and Gene Rearrangements in Lung Cancer: Present and Developing Technologies 11. Mutational Events in Lung Cancer: Present and Developing Technologies 12. Epigenetic Events, Alterations, and Remodeling in Lung Cancer: Present and Developing Technologies 13. Stem Cells and Lung Cancer: In Vitro and In Vivo Studies 14. Microenvironment and Lung Cancer 15. MicroRNAs as Biomarkers for Lung Cancer Section 3: Immunology 16. Humoral and Cellular Immune Dysregulation and Lung Cancer Section 4: Pathology 17. Classic Anatomic Pathology and Lung Cancer 18. Molecular Testing and Lung Cancer 19. Management of the Small Biopsy in the Molecular Er Section 5: Clinical and Radiologic Presentation of Lung Cancer 20. Clinical Presentation 21. Conventional Imaging Lung Cancer 22. PET Imaging of Lung Cancer Section 6: Diagnosis and Staging of Lung Cancer 23. Diagnostic Work-Up of Suspected Lung Cancer 24. Surgical Staging of the Mediastinum including Mediastinoscopy and Thoracoscopy, Preoperative and Intraoperative 25. The 8th Edition of the Tumor, Node and Metastasis Classification of Lung Cancer Section 7: Surgical Management of Lung Cancer 26. Preoperative Functional Evaluation of the Surgical Candidate 27. Results of Video Assisted Techniques for Resection of Lung Cancer 28. Results of Robotic Techniques for Resection of Lung Cancer 29. Extent of Surgical Resection for Stage I and II Lung Cancer 30. Extended Resections for Lung Cancer: Chest Wall and Pancoast Tumors 31. Extended Resections for Lung Cancer: Broncho/Vascular Sleeve Resections 32. Multiple Nodules: Management of the Patient with Synchronous or Metachronous Lung Cancers 33. Surgical Management of the Marginally Resectable Patient Section 8: Radiotherapeutic Management of Lung Cancer 34. Technical Requirements for Lung Cancer Radiotherapy 35. Radiobiology of Lung Cancer 36. Patient Selection for Radiotherapy 37. Stage I Non-Small Cell Lung Cancer and Oligometastatic Disease 38. Ablation Options for Localized Lung Cancer 39. Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer, including Combined Modality 40. Radiotherapy in the Management of Small Cell Lung Cancer: Thoracic Radiotherapy, Prophylactic Cranial Irradiation 41. Palliative Radiotherapy for Lung Cancer: Locoregional and Metastatic 42. Acute and Late Toxicities of Thoracic Radiotherapy: Pulmonary, Esophagus, Heart 43. Treatment-Related Neurotoxicity, Medical and Radiation Therapy Section 9: Chemotherapy and Targeted Agents for Lung Cancer 44. Front-Line Systemic Options in Non-Small Cell Lung Cancer 45. Systemic Options in Second Line and Beyond 46. Maintenance Therapy in NSCLC 47. Pharmacogenomics and Lung Cancer 48. New Targetable Pathways in Lung Cancer 49. Management of Toxicities of Targeted Therapies 50. Immunotherapy and Lung Cancer 51. Systemic Therapy in Early-Stage NSCLC 52. Treatment of Small-Cell Lung Cancer Section 10: Other Thoracic Malignancies 53. Malignant Mesothelioma 54. Mediastinal Tumors 55. Neuroendocrine Tumors of the Lung Other than SCLC 56. Thymic Cancer/Thymoma Section 11: Symptom Management and Complications 57. Lung Cancer Emergencies 58. Role of Palliative Care in Lung Cancer Section 12: Clinical Trials 59. Methodology of Clinical Trials in Lung Cancer 60. How to Promote and Organize Clinical Research in Lung Cancer Section 13: Thoracic Oncology Advocacy 61. Role of Advocacy Groups in Lung Cancer 62. Health Services Research in Lung Cancer Appendix 63. Appendix: Diagnostic Algorithms

    Out of stock

    £999.99

  • OncoNephrology

    Elsevier - Health Sciences Division OncoNephrology

    Out of stock

    Book SynopsisTable of ContentsSECTION 1 Fluid and Electrolyte Disorders in Cancer Patients 1 Kidney Function 2 Dysnatremias in Cancer 3 Potassium Disorders 4 Calcium and Phosphorus Disorders 5 Volume Disorders and Fluid Resuscitation SECTION 2 Paraprotein-Related Kidney Diseases 6 Paraproteins 7 Cast Nephropathy 8 Systemic Light Chain Amyloidosis 9 Monoclonal Immunoglobulin Deposition Disease 10 Fibrillary and Immunotactoid Glomerulonephritis SECTION 3 Hematopoietic Stem Cell Associated Kidney Disease 11 Hematopoietic Cell Transplant Associated Kidney Injury 12 Sinusoidal Obstruction Syndrome 13 Thrombotic Microangiopathy 14 Graft-Versus-Host Disease 15 Chronic Kidney Disease, End-Stage Renal Disease, and Bone Marrow Transplant SECTION 4 Chemotherapy and Radiation Related Kidney Diseases 16 Conventional Chemotherapy 17 Targeted Cancer Therapies (Biologics) 18 Adverse Kidney Effects of Immunotherapies 19 Chemotherapy in Chronic Kidney Disease and Dialysis 20 Radiation Nephropathy SECTION 5 Paraneoplastic Glomerulopathies 21 Paraneoplastic Glomerular Diseases 22 Paraneoplastic Glomerulonephritis 23 Hematologic Malignancies 24 Cancer Screening Recommendations SECTION 6 Renal Tumors 25 Renal Cell Cancer 26 Wilms Tumor and von Hippel Lindau Disease 27 Tuberous Sclerosis Complex and the Kidney 28 Evaluation of a Renal Cyst/Mass SECTION 7 Acute Kidney Injury 29 Acute Kidney Injury Incidence, Pathogenesis, and Outcomes 30 Tumor Lysis Syndrome 31 Obstructive Nephropathy in Cancer 32 Renal Replacement Therapies SECTION 8 Chronic Kidney Disease and Cancer 33 Chronic Kidney Disease as a Complication of Cancer, With Special Focus on Kidney and Urothelial Tumors 34 Incidence of Cancer and Screening Recommendations 35 Cancer in Renal Transplant Patients SECTION 9 Kidney Infections 36 Renal Infections in Cancer Patients SECTION 10 Infiltrative Diseases 37 Kidney Disease in Leukemia 38 Kidney Disease in Lymphoma

    Out of stock

    £999.99

  • Diagnostic Imaging Oncology

    Elsevier - Health Sciences Division Diagnostic Imaging Oncology

    Out of stock

    Book SynopsisTable of ContentsHead & Neck Lip and Oral Cavity Carcinoma Oropharynx (p16-) and Hypopharynx Carcinoma HPV-Mediated (p16+) Oropharyngeal Carcinoma Nasopharynx Carcinoma Larynx Carcinoma Nasal Cavity and Paranasal Sinuses Carcinoma Salivary Gland Carcinoma Differentiated and Anaplastic Thyroid Carcinoma Thorax Lung Carcinoma Malignant Pleural Mesothelioma Thymus Carcinoma Breast Breast Carcinoma Gastrointestinal Sites Soft Tissue Sarcoma of Abdomen and Thoracic Visceral Organs Soft Tissue Sarcoma of Retroperitoneum Esophagus and Esophagogastric Junction Carcinoma Stomach Carcinoma Small Intestine Carcinoma Appendix Carcinoma Neuroendocrine Tumors of the Appendix Colorectal Carcinoma Anus Carcinoma Gastrointestinal Stromal Tumor Neuroendocrine Tumors of Duodenum and Ampulla of Vater Neuroendocrine Tumors of Colon and Rectum Neuroendocrine Tumors of Jejunum and Ileum Neuroendocrine Tumors of Stomach Hepatocellular Carcinoma Gallbladder Carcinoma Intrahepatic Bile Duct Carcinoma Perihilar Bile Duct Carcinoma Distal Bile Duct Carcinoma Ampulla of Vater Carcinoma Neuroendocrine Tumors of Pancreas Exocrine Pancreas Carcinoma Genitourinary Sites Adrenal Cortical Carcinoma Adrenal Neuroendocrine Tumors Renal Cell Carcinoma Renal Pelvis and Ureter Carcinoma Urinary Bladder Carcinoma Urethra Carcinoma Prostate Carcinoma Testis Carcinoma Gynecologic Sites Cervix Uteri Carcinoma Corpus Uteri Carcinoma Ovary, Fallopian Tube, and Primary Peritoneal Carcinoma Vaginal Carcinoma Vulvar Carcinoma Gestational Trophoblastic Neoplasms Musculoskeletal Sites Primary Malignant Bone Tumor Multiple Myeloma Soft Tissue Sarcoma Systemic Malignancies Hodgkin and Non-Hodgkin Lymphomas Melanoma of Skin

    Out of stock

    £999.99

  • Handbook of Cancer TreatmentRelated Symptoms and

    Elsevier - Health Sciences Division Handbook of Cancer TreatmentRelated Symptoms and

    Out of stock

    Book SynopsisTable of ContentsPart 1. Cytotoxic Chemotherapy 1. Mechanism of Chemotherapy in Cancer Treatment 2. Neutropenic Complications of Chemotherapy 3. Chemotherapy Induced Anemia 4. Cancer Treatment Related Thrombocytopenia 5. Oral Mucositis 6. Gastrointestinal Complications of Chemotherapy 7. Neurological Complications 8. Pulmonary Toxicities of Cytotoxic Chemotherapy 9. Dermatological Complications of Chemotherapy 10. Cardiotoxicities of Chemotherapy 11. Management of Cancer Treatment Infusion Reactions Part 2. Targeted Therapies 12. Mechanism of Targeted Therapies in Cancer Treatment 13. Gastrointestinal Complications 14. Pulmonary Toxicities of Molecular Targeted Therapies 15. Dermatologic Toxicities 16. Cardiotoxicities Part 3. Immunotherapies 17. Mechanism of Immune-Related Adverse Events 18. Endocrine Toxicities 19. Gastrointestinal Toxicities 20. Neurological Complications of Immunotherapy 21. Pulmonary Toxicities 22. Dermatological Complications 23. Immunotherapy-Induced Cardiotoxicities 24. Rheumatological Complications Part 4. Radiation Therapy 25. Mechanisms of Radiation-Related Toxicities 26. Radiation-Induced Mucositis and Esophagitis 27. Radiation Therapy Related Dermatologic Toxicities 28. Pulmonary Toxicity from Radiation Therapy 29. Radiation-Induced Cardiotoxicities

    Out of stock

    £999.99

  • Elsevier - Health Sciences Division Gunderson and Teppers Clinical Radiation Oncology

    Out of stock

    Book SynopsisTable of ContentsSECTION I SCIENTIFIC FOUNDATIONS OF RADIATION ONCOLOGY Part A. Radiobiology 1. The Biological Basis of Radiation Oncology 2. Molecular and Cellular Biology 3. Dose-Response Modifiers in Radiation Therapy 4. Interaction of Chemotherapy and Radiation 5. Biologics and Their Interactions with Radiation Part B. Physics 6. Radiation Oncology Physics 7. Radiation Physics - Stereotactic Part C. Related Cancer Disciplines 8. Surgical Principles 9. Principles of Chemotherapy 10. Imaging in Oncology 11. Nuclear Medicine 12. Health Services Research in Radiation Oncology 13. Statistics and Clinical Trials 14. Late Effects after Radiation SECTION II TECHNIQUES AND MODALITIES 15. Brachytherapy 16. Intensity-Modulated and Image-Guided Radiation Therapy 17. Intraoperative Irradiation 18. Total Body Irradiation 19. Charged Particle Radiotherapy 20. Neutron Radiotherapy 21. Hyperthermia 22. Targeted Radionuclide Therapy 23. Stereotactic Irradiation: CNS Tumors 24. Stereotactic Body Irradiation: Extracranial Tumors 25. Metastatic Disease: Bone, Spinal Cord, Brain, Liver, and Lung SECTION III DISEASE SITES Part A. Central Nervous System Tumors Overview 26. Low-Grade Gliomas 27. High-Grade Gliomas 28. Benign Brain Tumors: Meningiomas and Vestibular Schwannomas 29. Pituitary Tumors and Craniopharyngiomas 30. Spinal Cord Tumors 31. Orbital, Ocular, and Optic Nerve Tumors Part B. Head and Neck Tumors Overview 32. Oral Cavity 33. Oropharyngeal Cancer 34. Nasopharyngeal Carcinoma 35. Larynx and Hypopharynx Cancer 36. Sinonasal Cancer 37. Salivary Gland Malignancies 38. Thyroid Cancer 39. Unknown Head and Neck Primary Site 40. Management of the Neck 41. Cutaneous Carcinoma 42. Malignant Melanoma Part C. Thoracic Neoplasms Overview 43. Small Cell Lung Cancer 44. Non-Small Cell Lung Cancer 45. Cancer of the Esophagus 46. Uncommon Thoracic Tumors Part D. Gastrointestinal Tumors Overview 47. Gastric/GE Junction Cancer 48. Pancreatic Cancer 49. Hepatobiliary Cancer 50. Colon Cancer 51. Rectal Cancer 52. Anal Carcinoma Part E. Genitourinary Tumors Overview 53. Prostate Cancer 54. Bladder Cancer 55. Testicular Cancer 56. Kidney and Ureteral Carcinoma 57. Penile Cancer Part F. Gynecologic Tumors Overview 58. Cervical Cancer 59. Endometrial Cancer 60. Cancers of the Vulva and Vagina 61. Ovarian Cancer Part G. Breast Cancer Overview 62. Noninvasive Breast Cancer 63. Breast Cancer: Stages I-II 64. Breast Cancer: Postmastectomy Radiation, Locally Advanced Disease, and Inflammatory Breast Cancer Part H. Sarcoma and Benign Disease 65. Soft Tissue Sarcoma 66. Benign Diseases Part I. Childhood Cancers Overview 67. Central Nervous System Tumors 68. Pediatric Soft Tissue Sarcomas 69. Pediatric Sarcomas of Bone 70. Wilms' Tumor 71. Retinoblastoma 72. Neuroblastoma 73. Pediatric Leukemias and Lymphomas 74. Pediatric Hodgkin's Lymphoma 75. Rare Pediatric Tumors Part J. Lymphoma and Hematologic Malignancies Overview 76. Hodgkin's Lymphoma 77. Non-Hodgkin's Lymphoma 78. Multiple Myeloma and Other Plasma Cell Neoplasms 79. Mycosis Fungoides

    Out of stock

    £212.39

  • CardioOncology Practice Manual A Companion to

    Elsevier - Health Sciences Division CardioOncology Practice Manual A Companion to

    Out of stock

    Book SynopsisTrade Review"Overall, the book provides a succinct blueprint for the field of cardio-oncology. It informs its readers of the ideology necessary to provide quality clinical care in this specific area of medicine and shapes the direction that the field of cardio-oncology will likely take as its importance continues to increase over the coming years." ©Doody's Review Service, 2022, Joseph T Hale, MD MPH Candidate (East Tennessee State University Quillen College of Medicine) Doody's Score: 4 Stars!Table of Contents1. The Cardio-Oncology Clinic Part I. Cardiovascular Disease Management Before Cancer Treatment Section A. The A-to-Z Before Therapy 2. Key Points of Cardio-Oncology Evaluation Before Cancer Therapy 3. Chemotherapeutic Risks Before Cancer Therapy 4. Radiation Therapy Risks Before Cancer Therapy 5. Bone Marrow Transplantation Risks Before Cancer Therapy 6. Surgical Risks Before Cancer Therapy Section B. Cardiovascular Disease Prevention in Cancer Patients 7. Cardiomyopathy/Heart Failure Prevention Before Cancer Therapy 8. Vascular Disease Prevention Before Cancer Therapy 9. Thromboembolic Disease Prevention Before Cancer Therapy 10. Arrhythmia Prevention and Device Management Before Cancer Therapy 11. Hypertension and Renal Disease Prevention Before Cancer Therapy 12. Pulmonary Disease Prevention Before Cancer Therapy 13. Cardiopulmonary Exercise for Prevention Before Cancer Therapy Part II. Cardiovascular Disease Management During Cancer Treatment Section C. The A-to-Z Through Therapy 14. Key Points of Cardio-Oncology Evaluation During Cancer Therapy 15. Cardiomyopathy/Heart Failure Myocarditis, and Takotsubo's During Cancer Therapy 16. Structural Heart Disease 17. Vascular Disease 18. Thromboembolic Disease 19. Arrhythmia, QTc Prolongation, and Device Management 20. Hypertension and Renal Disease 21. Pulmonary Disease 22. Cardiovascular Imaging Part III. Cardiovascular Disease Management After Cancer Treatment Section D. The A-to-Z After Therapy 23. Key Points of Cardio-Oncology Evaluation After Cancer Therapy 24. Cancer Survivorship and Co-Morbidity Disease Risk 25. Long-Term Complications of Chemotherapy 26. Long-Term Complications of Radiation Therapy Section E. Cardiovascular Disease in Cancer Survivors 27. Cardiomyopathy/Heart Failure Prevention and Management 28. Structureal Heart Disease Prevention and Management 29. Vascular Disease Prevention and Management 30. Thromboembolic Disease Prevention and Manageent 31. Arrhythmia Prevention and Management 32. Hypertension and Renal Failure Prevention and Management 33. Pulmonary Disease Prevention and Management 34. Cardiopulmonary Rehabilitation Section F. Cardiovascular Disease Management in Specific Malignant Diseases 35. Breast Cancer 36. Uterine, Ovary, and Cervical Cancer 37. Prostate and Testicular Cancer 38. Renal and Urinary Bladder Cancer 39. Lung Cancer 40. Colorectal Cancer 41. Esophageal and Gastric Cancer 42. Hepatobiliary Carcinomas 43. Pancreatic Cancer 44. Melanoma 45. Head-and-Neck Cancers 46. Thyroid cancer 47. Glioblastoma 48. Bone and Soft Tissue Sarcomas 49. Leukemias 50. Lymphomas 51. Multiple Myeloma and Cardiac Amyloidosis 52. Carcinoid 53. Cardiac Masses Part IV. Cancer Drugs 54. Cancer Therapeutic Drug Guide

    Out of stock

    £999.99

  • DiSaia and Creasman Clinical Gynecologic Oncology

    Elsevier - Health Sciences Division DiSaia and Creasman Clinical Gynecologic Oncology

    Out of stock

    Book SynopsisTrade Review"This book provides a comprehensive overview of the clinical management of various gynecologic conditions. This tenth edition updates the previous version, which was published in 2018." ©Doody's Review Service, 2023, Sydney P Oesch, MD (University of Texas Southwestern Medical Center) Doody's Score: 4 Stars!Table of Contents1) Pre Invasive Disease of the Cervix a. Stu Massad 2) Pre Invasive Disease of the Vagina and Vulva and related disorders a. Cara Matthews and Joan Walker 3) Invasive Cervical Cancer a. Krish Tewari and Brad Monk 4) Endometrial Hyperplasia, Estrogen Therapy, and the Prevention of Endometrial Cancer a. Lisa Landrum and Rosemary Zuna and Joan Walker 5) Adenocarcinoma of the Uterine Corpus a. William Creasman and David Scott Miller 6) Sarcoma of the Uterus a. Scott McMeeken and William Creasman 7) Gestational Trophoblastic Disease a. Emma Barber and John Soper 8) Invasive Cancer of Vulva a. Thomas Herzog 9) Invasive Cancer of the Vagina a. Marilyn Huang, Brian Slomovitz and Rob Coleman 10) Adnexal Masses a. Camille Gunderson and Robert Mannel 11) Epithelial Ovarian Cancer a. Eric Eisenhauer, Ritu Salani and Larry Copeland 12) Germ Cell, Stromal and other ovarian tumors a. Emily Pennock, Chad Hamilton, Larr Maxwell and Charlotte Marcus 13) Fallopian tube cancer a. Eric Hope, G Larry Maxwell, and Chad Hamilton 14) Breast Diseases a. Patricia Cronin and Mary Gemignani 15) Cancer in Pregnancy a. Krish Tewari 16) Complications of Disease and Therapy a. Kemi Doll and Dan Clarkepearson 17) Basic Principles of Chemotherapy a. Christina Chu and Steve Rubin 18) Targeted therapy and Molecular Genetics a. Shannon Westin, Anil Sood and Rob Coleman 19) Genes and Cancer: Genetic Counselling and Clinical Management a. David Mutch, Sheri Babb and Phil Disaia 20) Palliative Care and Quality of Life a. Dana Chase, Siu-Fun Wong, Lari Wenzel and Brad Monk 21) Role of Minimally Invasive surgery in Gynecologic Malignancies a. Floor Backes, David Cohn, Robert Mannel and Jeff Fowler 22) Epidemiology of Commonly Used Statistical Terms and Analysis of Clinical Studies a. Wendy Brewster 23) Basic Principles in Gynecologic Radiotherapy a. Catheryn Yashar Appendix A: Staging: Staging of Cancer at Gynecologic Sites a) Mutch B: Modified from Common Terminology Criteria for Adverse events (common terminology criteria for adverse events). C: Blood component therapy D: Suggested recommendations for routine cancer screening E: Nutritional Therapy: Index

    Out of stock

    £999.99

  • Diffusion MRI of the Breast

    Elsevier - Health Sciences Division Diffusion MRI of the Breast

    Out of stock

    Book SynopsisTable of ContentsIntroduction A- Basics of breast diffusion MRI - General principles and challenges of diffusion MRI (Le Bihan, Iima, Partridge) This section will provide the physical basis of Diffusion MRI, give the key concepts necessary to understand and use DWI in clinical practice B- Breast Clinical Applications - Overview of conventional breast imaging (MMG, US, MRI except DWI) (Mann and/or Kuhl) This chapter will give a general overview of the field of breast imaging, with pros and cons, to help positioning DWI among all other approaches - Overview of breast DWI: Diagnosis of suspicious lesions using DWI in combination with standard MRI (20 pages) (Baltzer, Clauser, Gilbert) This chapter will review how DWI is currently used as a breast imaging modality and how breast lesions appear with DWI - Biomarkers, prognosis and prediction factors (10 pages) (Iima, Moy) This chapter will explain how DWI could be specifically used to provide information on prognosis and prediction factors (eg Her, Pg, ER, Ki67 receptors expression) and help lesion management - Disease and treatment monitoring (10 pages) (Partridge, Hylton, Li) This chapter will provide guidance on how DWI can be used to manage breast lesions, from diagnosis to treatment monitoring, using examples for most common types of lesions - Diffusion MRI as a stand-alone unenhanced breast imaging approach and screening (10 pages) (Amornsiripanitch, Hee Jung Shin, Partridge) This chapter will foresee how DWI could be used as a stand-alone approach (without DCE): patient population, technical requirement - DWI and breast physiology status (menstrual cycle, pregnancy, lactation) (10 pages) (Iima, Nissan) This chapter will review how changes in hormonal context and physiology may affect appearance of DWI normal breast tissues and lesions C- Challenges and Advanced Techniques - IVIM/perfusion Non-Gaussian diffusion (20 pages) (Sigmund, Iima, Le Bihan) This chapter will show how tissue microcirculation (perfusion) can be obtained from DWI without the need for tracers or contrast agent, explain why boosting sensitivity to diffusion provides added contrast and information on tissue microstructure, and how to combine both approaches in a clinical setting - DTI (20 pages) (Sigmund, Partridge) This chapter will explain how Diffusion Tensor Imaging could potentially reveal oriented features in the breast (eg ducts) and how lesions might modify them - Tissue characterization, radiomics, Artificial Intelligence, multiparametric imaging and integration of diffusion MRI to BIRADS (20 pages) (Pinker, Morris) This chapter will explain how DWI could be combined to other advanced breast imaging approaches to provide higher sensitivity, specificity and prognosis - Novel/Alternative Acquisition Techniques - (20 pages) o DWIBS (Takahara) o MS-EPI, RS-EPI, SMS, RSI, etc - (Hargreaves) Those short chapters will provide glances at novel or alternative methods to perform DWI with specific focus for breast applications D- Let us get practical - Clinical interpretation of diffusion MRI, ROI assessment, common errors, pitfalls and artifacts, challenges in acquisition (20 pages) (Gilbert, Patterson) This chapter will provide guidance on the interpretation of DWI in the breast, qualitatively and quantitatively, showing how common errors can be avoided and artifacts corrected - Quality control, standardization, test-objects (20 pages) (Chenevert, Newitt, Malyarenko, Keenan) This chapter will provide guidance on how to optimize DWI protocols, verify and control settings to obtain accurate and reproducible results

    Out of stock

    £999.99

  • Manual of Hematopoietic Cell Transplantation and

    Elsevier - Health Sciences Division Manual of Hematopoietic Cell Transplantation and

    Out of stock

    Book SynopsisTable of ContentsPart One Introduction Ch 1 Evolution of HCT, past, present, and future Ch 2 Human leukocyte antigen Ch 3 Introduction and basic science of chimeric antigen receptor therapies Ch 4 Statistical methods in HCT and cellular therapies Part Two Methodology Ch 5 Hematopoietic cell collection; bone marrow harvesting, apheresis, UCB Ch 6 Leukapheresis and manufacturing of CAR cells Part Three General Clinical Aspects Ch 7 Patient and donor selection and preparing for HCT Ch 8 General management of patients undergoing HCT Ch 9 Haploidentical HCT Ch 10 Umbilical cord blood transplantation Ch 11 Process and general management of patients undergoing CAR therapies Part Four Pharmacology and Radiation Therapy Ch 12 Preparative regimens used in HCT and CAR therapies Ch 13 Pharmacology of drugs used in HCT and CAR therapies Ch 14 Role of radiation therapy in HCT and CAR therapies Part Five Disease-Specific Indications and Results Ch 15 HCT in AML Ch 16 CAR therapy in AML Ch 17 HCT in ALL Ch 18 CAR therapy in ALL Ch 19 HCT in chronic leukemias; CML and CLL Ch 20 HCT in MDS Ch 21 HCT in myeloproliferative disorders Ch 22 HCT in aplastic anemia Ch 23 HCT in multiple myeloma Ch 24 CAR therapy in multiple myeloma Ch 25 HCT in light-chain amyloidosis Ch 26 HCT in NHL Ch 27 HCT in Hodgkin lymphoma Ch 28 CAR therapy in lymphoma Ch 29 HCT in rare malignancies Ch 30 HCT for hematologic malignancies in HIV patients Ch 31 HCT in solid tumors Part Six Prevention and Management of Complications Ch 32 Infectious complications Ch 33 Graft failure Ch 34 Graft-versus-host disease Ch 35 Miscellaneous complications of HCT Ch 36 Cytokine release syndrome Ch 37 Neurologic complications of CAR therapy (ICANS) Ch 38 Miscellaneous complications of CAR therapy Ch 39 Symptoms management and palliative care Ch 40 Survivorship

    Out of stock

    £999.99

  • Diagnosis and Treatment of Rare Gynecologic

    Elsevier - Health Sciences Division Diagnosis and Treatment of Rare Gynecologic

    Out of stock

    Book SynopsisTrade Review"This is an easy-to-read resource on rare gynecological cancers for those in the field. Each chapter is comprehensive and self-standing, preventing flipping back and forth to other chapters to find pertinent material. There are useful figures and tables to summarize the content and to give an at-a-glance, quick view of the key information covered in the chapter. The book is very up to date and addresses all therapies that are currently used in gynecological cancers.The ebook is easy to navigate and provides access to the book in its entirety." ©Doody's Review Service, 2023, Dandi Huang, MD(Cedars-Sinai Medical Center). Doody's Score: 4 Stars!Table of ContentsContributor Information: Please list names/affiliations of any contributors (can be tentative): Section 1 - Ovarian Cancer Malignant Germ Cell Tumors Sex Cord-Stromal Tumors Malignant Mixed Mesodermal Tumor Clear Cell Carcinoma Mucinous Carcinomas Low-Grade Serous Tumors (MPSC) and Variants Small Cell (hypercalcemic) Other rare ovarian cancers (Small Cell Carcinoma (hypercalcemic), Small Cell Carcinoma (Neuroendocrine, Mesolthelioma, Squamous Cell, Sarcomas) Section 2 - Uterine Cancer Leiomyosarcoma Other sarcomas of the uterus (Endometrial Stromal Sarcoma, STUMP, adenosarcoma) Carcinosarcoma Uterine Serous Carcinoma Other rare uterine cancers (Choriocarcinoma, Yolk Sac, Neuroendocrine) Section 3 - Cervical Cancer High Grade Neuroendocrine Carcinoma Other rare cervical cancers (Verrucous Carcinoma, Clear Cell Carcinoma, Adenoid Cystic Carcinoma, Rhabdomyosarcoma) Section 4 - Vulvovaginal Cancers Clear Cell Carcinoma Melanoma Bartholin Gland Carcinoma Benign and Malignant Paget's Disease Other rare vulvovaginal carcinomas (Verrucous Carcinoma, Embryonal Rhabdomyosarcoma, Yolk Sac Tumor, Aggressive Angiomyxoma, Sarcomas Section 5 - Trophoblastic Disease Gestational Trophoblastic Disease and Placental Site Trophoblastic Tumor

    Out of stock

    £999.99

  • Palliative Radiation Oncology

    Elsevier - Health Sciences Division Palliative Radiation Oncology

    Out of stock

    Book SynopsisTrade Review"This book addresses palliative care in radiation oncology from a multi-dimensional perspective and includes an ebook component. The website resources provide quick links to cited references, but offer limited additional features beyond the convenience of expanded access to the book." ©Doody's Review Service, 2023, Mark D. Hurwitz, MD (New York Medical College) Doody's Score: 4 Stars!Table of ContentsSECTION I Foundations and Principles of Palliative Care in Oncology 1 Definition of Palliative Care 2 Introduction to Prognostication 3 Basic Communication Frameworks 4 Troubleshooting Difficult Conversation 5 Models of Multidisciplinary Management SECTION II Techniques and Modalities 6 Palliative Radiation 7 Selecting Modalities 8 Treatment Planning in Palliative Radiotherapy 9 Alternate Modalities for Palliation 10 Combining Radiation and Systemic Therapy 11 Considerations Involving Reirradiation SECTION III Foundations and Principles of Palliative Radiation by Body Site or Special Population 12 Palliative Radiotherapy in the Head and Neck 13 Palliative Thoracic Radiation 14 Palliative Radiotherapy in the Breast and Chest Wall 15 Palliative Radiotherapy for Gastrointestinal Malignancies 16 Palliative Radiotherapy for Gynecologic Malignancies 17 Palliative Radiotherapy in Pediatrics 18 Radiotherapeutic Palliation of Lymphoma 19 Radiotherapeutic Palliation of Bone Marrow Diseases-Leukemia and Multiple Myeloma 20 Palliative Radiotherapy in Bones 21 Palliative Radiotherapy in the Brain 22 Palliative Radiotherapy in the Spine 23 Palliative Radiotherapy in Oligometastases 24 Palliative Radiotherapy in the Older Adult SECTION IV Management of Symptoms and Treatment- Related Toxicities 25 General Symptom Overview: Importance of Side Effect Management, CINV, Anorexia, and Cachexia 26 Management of Pain 27 Management of Fatigue 28 Management of Skin Toxicity 29 Central Nervous System: Symptoms and Toxicities 30 Management of Symptoms and Treatment-Related Toxicities of Head and Neck Cancers 31 Chest and Thorax: Symptoms and Toxicities 32 Abdomen and Pelvis: Symptoms and Toxicities 33 Late Toxicities Management 34 Psychosocial and Spiritual Distress Index

    Out of stock

    £999.99

© 2026 Book Curl

    • American Express
    • Apple Pay
    • Diners Club
    • Discover
    • Google Pay
    • Maestro
    • Mastercard
    • PayPal
    • Shop Pay
    • Union Pay
    • Visa

    Login

    Forgot your password?

    Don't have an account yet?
    Create account